Just a theory, absolutely no proof whatsoever -
Many health stocks have continued on their merry way higher, even if there's been an overall falling away of the overall market. IMO the investors/speculators etc that have made (and probably are continuing to make) money from such investments have combed the health sector for likely future candidates - and obviously EBR fits right into that category.
It remains a highly discounted opportunity, just counting down the days towards FDA submission. At some point it will likely go through a significant rerating, but thats probably still some time away, lnowing that the FDA submission is anticipated for 3Q 24.
General Investor Information EBR Systems, page-246
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
0.035(3.37%) |
Mkt cap ! $331.2M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.08 | $1.02 | $106.3K | 101.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 17975 | 1 |
View Market Depth
| Last trade - 15.59pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
0.035 ( 6.15 %) |
||||
| Open | High | Low | Volume | ||
| $1.03 | $1.08 | $1.02 | 46378 | ||
| Last updated 14.58pm 17/06/2024 ? | |||||
| EBR (ASX) Chart |
